Ryuji Kaji

Q: What Schools Are Affiliated With Ryuji Kaji

Ryuji Kaji is affiliated with the following schools: University of Tokushima, Kyoto University

Ryuji Kaji's AcademicInfluence.com Rankings

Ryuji Kaji

Biology

#12506

World Rank

#15985

Historical Rank

Neuroscience

#2105

World Rank

#2163

Historical Rank

biology Degrees

Download Badge

Biology

Ryuji Kaji's Degrees

PhD Neuroscience University of Tokyo
Bachelors Biology University of Tokyo

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Ryuji Kaji Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ryuji Kaji's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mutations of optineurin in amyotrophic lateral sclerosis (2010) (1150)
Electrodiagnostic criteria for diagnosis of ALS (2008) (943)
Mutations in COQ2 in familial and sporadic multiple-system atrophy. (2013) (246)
Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. (2004) (225)
KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier (2006) (207)
Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. (2007) (204)
Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. (2003) (204)
Abnormal premovement gating of somatosensory input in writer's cramp. (2000) (181)
Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. (2002) (172)
A proposal for new diagnostic criteria for ALS (2020) (171)
Pain-related somatosensory evoked potentials following CO2 laser stimulation of foot in man. (1989) (170)
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial (2010) (165)
The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis (2017) (164)
Functional anatomy of the basal ganglia in X‐linked recessive dystonia‐parkinsonism (2005) (162)
The anatomical basis of dystonia: Current view using neuroimaging (2013) (158)
Dissociation between contingent negative variation (CNV) and Bereitschaftspotential (BP) in patients with parkinsonism. (1997) (139)
F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy (2000) (137)
Increased Frequency of Interleukin‐1β‐511T Allele in Patients with Temporal Lobe Epilepsy, Hippocampal Sclerosis, and Prolonged Febrile Convulsion (2003) (135)
Focal ictal direct current shifts in human epilepsy as studied by subdural and scalp recording. (1999) (135)
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy (2011) (135)
The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. (1997) (134)
Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies (2003) (133)
iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer's Disease. (2017) (127)
A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. (1995) (113)
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. (2012) (105)
Abnormal cortical mechanisms of voluntary muscle relaxation in patients with writer's cramp: an fMRI study. (2002) (100)
Botulinum toxin type A in post-stroke upper limb spasticity (2010) (98)
Variants associated with Gaucher disease in multiple system atrophy (2015) (97)
The El Escorial criteria: Strengths and weaknesses (2015) (97)
Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy (1994) (95)
Nerve excitability testing and its clinical application to neuromuscular diseases (2006) (95)
Presence of Bereitschaftspotential preceding psychogenic myoclonus: clinical application of jerk-locked back averaging. (1995) (94)
Stress control and human nutrition. (2004) (93)
Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia (2008) (90)
Physiological study of cervical dystonia. Task-specific abnormality in contingent negative variation. (1995) (90)
Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease (2001) (90)
Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia (2008) (89)
Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. (2004) (87)
Basal ganglia as a sensory gating devise for motor control. (2001) (87)
Dissociation between contingent negative variation and Bereitschaftspotential in a patient with cerebellar efferent lesion. (1994) (82)
Activity-dependent conduction block in multifocal motor neuropathy. (2000) (79)
Abnormal cortical processing of voluntary muscle relaxation in patients with focal hand dystonia studied by movement-related potentials. (1999) (78)
Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients (2015) (76)
Activity-dependent conduction block in multifocal motor neuropathy (2006) (71)
Comparison of Therapeutic Efficacies of Type A and F Botulinum Toxins for Blepharospasm (1995) (71)
Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin? (2017) (71)
Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria? (2011) (71)
Abnormal excitability of the corticospinal pathway in patients with amyotrophic lateral sclerosis: a single motor unit study using transcranial magnetic stimulation. (1995) (70)
Which target is best for patients with Parkinson's disease? A meta-analysis of pallidal and subthalamic stimulation (2014) (70)
Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease (2009) (70)
Multifocal motor neuropathy and Lewis Sumner syndrome: A clinical spectrum (1999) (69)
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP (2005) (69)
Mutations in GNAL: a novel cause of craniocervical dystonia. (2014) (67)
Treatable inherited rare movement disorders (2018) (66)
Abnormal contingent negative variation in writer's cramp (1999) (66)
Age associated axonal features in HNPP with 17p11.2 deletion in Japan (2005) (65)
Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation (2011) (65)
Bilateral pallidal deep brain stimulation in primary Meige syndrome. (2011) (65)
Pre-movement gating of short-latency somatosensory evoked potentials. (1999) (65)
Epidemiology of primary dystonias in Japan: Comparison with Western countries (2003) (63)
Generator mechanism of pain-related evoked potentials following CO2 laser stimulation of the hand: scalp topography and effect of predictive warning signal. (1994) (63)
Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease (2006) (62)
Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test. (2011) (62)
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease (2009) (60)
Contribution of the interleukin‐1β gene polymorphism in multiple system atrophy (2002) (59)
Thinning of cervical nerve roots and peripheral nerves in ALS as measured by sonography (2014) (58)
Alleviation of camptocormia by bilateral subthalamic nucleus stimulation in a patient with Parkinson's disease. (2006) (56)
Nucling Recruits Apaf-1/Pro-caspase-9 Complex for the Induction of Stress-induced Apoptosis* (2004) (56)
Transsynaptic inhibition of spinal transmission by A2 botulinum toxin (2013) (55)
Development of general weakness in a patient with amyotrophic lateral sclerosis after focal botulinum toxin injection. (1996) (55)
Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp (1995) (55)
Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer’s disease (2004) (54)
Amyotrophic lateral sclerosis and motor neuron syndromes in Asia (2016) (54)
Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan (2009) (52)
Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: a retrospective evaluation of Japanese patients with Parkinson's disease. (2007) (52)
Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: Correlation with clinical profiles (2004) (52)
Relationship between Barthel Index scores during the acute phase of rehabilitation and subsequent ADL in stroke patients. (2010) (51)
Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism. (2013) (51)
A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. (2011) (51)
TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. (2003) (50)
Genome‐wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? (2014) (50)
Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis (2009) (50)
A multicentre prospective study of Guillain-Barré Syndrome in Japan: a focus on the incidence of subtypes (2013) (50)
Peri-rolandic and fronto-parietal components of scalp-recorded giant SEPs in cortical myoclonus. (1995) (49)
Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy (2018) (48)
Reduced alpha‐synuclein in cerebrospinal fluid in synucleinopathies: Evidence from a meta‐analysis (2014) (48)
Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation (2014) (47)
Measurement of axonal excitability: Consensus guidelines (2020) (44)
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study (2019) (44)
Neurogenic and Myogenic Diseases: Quantitative Texture Analysis of Muscle US Data for Differentiation. (2017) (43)
Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis (2015) (43)
Abnormal sensory gating in basal ganglia disorders (2005) (42)
Effect of repetitive transcranial magnetic stimulation applied over the premotor cortex on somatosensory-evoked potentials and regional cerebral blood flow (2006) (42)
Type A1 but not type A2 botulinum toxin decreases the grip strength of the contralateral foreleg through axonal transport from the toxin-treated foreleg of rats. (2011) (42)
Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients (2013) (41)
Neurological deterioration in small vessel disease may be associated with increase of infarct volume (2008) (41)
An electrophysiological study of the corticospinal projections in amyotrophic lateral sclerosis (1999) (41)
Brain‐derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy (2005) (41)
Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins. (2010) (40)
A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease (2014) (40)
Efficacy of Zolpidem for Dystonia: A Study Among Different Subtypes (2012) (40)
Undiminished regulatory T cells in the thymus of patients with myasthenia gravis (2010) (40)
THALAMIC VO-COMPLEX VS PALLIDAL DEEP BRAIN STIMULATION FOR FOCAL HAND DYSTONIA (2008) (39)
Factors influencing the therapeutic effect of muscle afferent block for oromandibular dystonia and dyskinesia: implications for their distinct pathophysiology. (2002) (39)
Association of partial epilepsy with brain-derived neurotrophic factor (BDNF) gene polymorphisms (2003) (39)
DYT1 mutation in Japanese patients with primary torsion dystonia (2001) (38)
Physiological consequences of antiserum-mediated experimental demyelination in CNS. (1988) (38)
Abnormal axonal inward rectifier in streptozocin-induced experimental diabetic neuropathy. (2001) (38)
A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with amyotrophic lateral sclerosis (2020) (38)
Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2 (2014) (38)
Glutathione‐S‐transferase‐1 and interleukin‐1β gene polymorphisms in Japanese patients with Parkinson's disease (2005) (38)
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial (2017) (37)
Comparison of monophasic versus biphasic stimulation in rTMS over premotor cortex: SEP and SPECT studies (2008) (37)
Immediate effect of spinal magnetic stimulation on camptocormia in Parkinson's disease (2014) (37)
Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt–Jakob disease patients (2012) (36)
Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy (2005) (36)
[Diagnosis and treatment of dystonia]. (2008) (36)
Could clinical diffusion-mismatch determined using DWI ASPECTS predict neurological improvement after thrombolysis before 3 h after acute stroke? (2010) (36)
The effect of istradefylline for Parkinson’s disease: A meta-analysis (2017) (36)
Increasing and persistent DWI changes in a patient with Hereditary Diffuse Leukoencephalopathy with Spheroids (2013) (35)
[Clinical trials of ultra-high-dose methylcobalamin in ALS]. (2007) (35)
Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia (2011) (35)
Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease (2003) (35)
Origin of short-latency somatosensory evoked potentials to median nerve stimulation in the cat. Comparison of the recording montages and effect of laminectomy. (1986) (35)
CSF cytokine profile distinguishes multifocal motor neuropathy from progressive muscular atrophy (2015) (34)
Movement‐related cortical potentials before jaw excursions in oromandibular dystonia (2003) (34)
Physiology of ALS and related diseases (1997) (34)
Cortical Potentials Associated with Voluntary Mandibular Movements (2000) (33)
Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses. (2010) (33)
Phenotype variability and allelic heterogeneity in KMT2B-Associated disease. (2018) (32)
Markers for Guillain‐Barré syndrome with poor prognosis: a multi‐center study (2017) (31)
[The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy]. (1999) (31)
Nuclear factor κ B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. (2012) (30)
Long‐term suppression of Meige syndrome after pallidal stimulation: A 10‐year follow‐up study (2010) (30)
Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force (2016) (30)
Anatomic Localization for Needle Electromyography (1995) (30)
Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential. (2012) (29)
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN (2016) (29)
Deep Brain Stimulation of the Thalamic Ventral Lateral Anterior Nucleus for DYT6 Dystonia (2014) (28)
Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. (2002) (28)
Compartmental loss of striatal medium spiny neurons in multiple system atrophy of parkinsonian type (2007) (28)
Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier (2013) (28)
Impact of bilateral pallidal stimulation on DYT1‐generalized dystonia in Japanese patients (2006) (28)
Olfactory type G-protein α subunit in striosome-matrix dopamine systems in adult mice (2010) (28)
Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs (2017) (27)
Brush Sign on 3-T T2*-Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy (2014) (27)
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis (2013) (27)
Intramuscular dissociation of echogenicity in the triceps surae characterizes sporadic inclusion body myositis (2016) (27)
Strategies for treatment of dystonia (2016) (26)
Sleep bruxism as a manifestation of subclinical rapid eye movement sleep behavior disorder. (1994) (26)
Neurologic attack and dynamic perfusion abnormality in neuronal intranuclear inclusion disease. (2017) (26)
Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: a potential compensatory role (2013) (26)
The Awaji criteria for diagnosis of ALS (2011) (26)
The difference in putamen volume between MSA and PD: evidence from a meta-analysis. (2014) (25)
Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease (2012) (25)
Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats. (2009) (25)
Two-Layered Susceptibility Vessel Sign on 3-Tesla T2*-Weighted Imaging Is a Predictive Biomarker of Stroke Subtype (2015) (25)
Multicentre multiobserver study of diffusion-weighted and fluid-attenuated inversion recovery MRI for the diagnosis of sporadic Creutzfeldt–Jakob disease: a reliability and agreement study (2012) (23)
Effects of a Brain-Engraftable Microglial Cell Line Expressing Anti-Prion scFv Antibodies on Survival Times of Mice Infected with Scrapie Prions (2011) (23)
Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy. (2002) (22)
Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats (2015) (22)
Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis (2015) (22)
The effects of FK506 on refractory inflammatory myopathies. (2011) (22)
Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis (2016) (21)
Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. (2003) (21)
Clinical differences between A1 and A2 botulinum toxin subtypes. (2015) (21)
Which muscle shows fasciculations by ultrasound in patients with ALS? (2016) (21)
Development of a highly sensitive immunohistochemical method to detect neurochemical molecules in formalin-fixed and paraffin-embedded tissues from autopsied human brains (2015) (21)
Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease (2012) (21)
Complete suppression of paroxysmal nonkinesigenic dyskinesia by globus pallidus internus pallidal stimulation (2006) (21)
[New diagnostic criteria of ALS (Awaji criteria)]. (2007) (21)
High‐resolution sonography detects inflammatory changes in vasculitic neuropathy (2006) (21)
Customized EMG needle insertion guide for the muscle afferent block of jaw-deviation and jaw-opening dystonias. (1999) (20)
Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice (2013) (20)
Cortical distribution of Bereitschaftspotential and negative slope potential preceding mouth-opening movements in humans. (1999) (20)
Early detection of familial Creutzfeldt-Jakob disease on diffusion-weighted imaging before symptom onset (2012) (20)
Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals. (2014) (20)
Increased proinflammatory cytokines in sera of patients with multifocal motor neuropathy (2014) (20)
Current source density mapping of somatosensory evoked responses following median and tibial nerve stimulation. (1992) (20)
Refinement of a locus for autosomal dominant hereditary motor and sensory neuropathy with proximal dominancy (HMSN-P) and genetic heterogeneity (2007) (20)
Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan (2020) (20)
ALS-parkinsonism-dementia complex of Kii and other related diseases in Japan. (2012) (20)
Facts and fallacies on anti-GM1 antibodies: physiology of motor neuropathies. (1999) (19)
The clinical characteristics of spinocerebellar ataxia 36 : A study of 2121 Japanese ataxia patients (2012) (19)
Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease. (2005) (19)
Deep learning for waveform identification of resting needle electromyography signals (2019) (19)
Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase I/II open label clinical trial. (2014) (19)
Global burden of neurological diseases highlights stroke (2019) (19)
Imaging-based differential diagnosis between multiple system atrophy and Parkinson's disease (2016) (19)
Lack of prolonged cerebral blood flow change after transcranial magnetic stimulation. (1993) (19)
Risk Factors of Neurological Deterioration in Patients with Cerebral Infarction due to Large-Artery Atherosclerosis. (2017) (18)
Guillain−Barré syndrome in a local area in Japan, 2006–2015: an epidemiological and clinical study of 108 patients (2018) (18)
Intra-Arterial Signal on Arterial Spin Labeling Perfusion MRI to Identify the Presence of Acute Middle Cerebral Artery Occlusion (2014) (18)
Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia–parkinsonism (2013) (18)
Brainstem and spinal cord motor neuron involvement with optineurin inclusions in proximal-dominant hereditary motor and sensory neuropathy (2011) (18)
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes (2017) (18)
Optimal Timing of Diffusion-Weighted Imaging to Avoid False-Negative Findings in Patients With Transient Ischemic Attack (2017) (18)
Multicenter questionnaire survey for sporadic inclusion body myositis in Japan (2016) (18)
Sonographic evaluation of cervical nerve roots in ALS and its clinical subtypes. (2016) (17)
Attenuation of MPTP‐induced neurotoxicity and locomotor dysfunction in Nucling‐deficient mice via suppression of the apoptosome pathway (2006) (17)
Memory B cell resurgence requires repeated rituximab in myasthenia gravis (2017) (17)
A homozygous mutation of VWA3B causes cerebellar ataxia with intellectual disability (2015) (17)
Influence of cytokine and mannose binding protein gene polymorphisms on human T-cell leukemia virus type I (hTLV-I) provirus load in HTLV-I asymptomatic carriers. (2003) (17)
Exome sequencing reveals a novel MRE11 mutation in a patient with progressive myoclonic ataxia (2014) (17)
Prevalence of inositol 1, 4, 5-triphosphate receptor type 1 gene deletion, the mutation for spinocerebellar ataxia type 15, in Japan screened by gene dosage (2012) (17)
Late-onset myasthenia gravis is predisposed to become generalized in the elderly (2016) (16)
Frequent hepatic steatosis in amyotrophic lateral sclerosis: Implication for systemic involvement (2015) (16)
Optimisation of botulinum treatment for cervical and axial dystonias: experience with a Japanese type A toxin. (1994) (16)
Clinicopathological Phenotype and Genetics of X-Linked Dystonia–Parkinsonism (XDP; DYT3; Lubag) (2017) (16)
Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome (2016) (16)
Depression in X-linked dystonia-parkinsonism: a case-control study. (2013) (16)
Sensory deficits in dystonia and their significance. (2004) (16)
Treatment of spasticity with muscle afferent block (1999) (16)
Inflammatory disease and cancer with a decrease in Kupffer cell numbers in Nucling‐knockout mice (2009) (15)
Proteasome impairment in neural cells derived from HMSN-P patient iPSCs (2017) (15)
Physiology and pathophysiology of myelinated nerve fibers. (2013) (15)
Molecular dissection and anatomical basis of dystonia: X-linked recessive dystonia-parkinsonism (DYT3). (2005) (15)
Cervical root sonography to differentiate multifocal motor neuropathy from ALS. (2016) (15)
Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study (2020) (15)
Dynamic change of proximal conduction in demyelinating neuropathies: A cervical magnetic stimulation combined with maximum voluntary contraction (2007) (15)
Comment from the editorial office (1991) (15)
Up-regulation of cyclooxygenase-2 in inflammatory demyelinating neuropathy (2001) (14)
Nucling interacts with nuclear factor‐κB, regulating its cellular distribution (2009) (14)
Peripheral Nerve Excitability Measures at Different Target Levels: The Effects of Aging and Diabetic Neuropathy (2010) (14)
Impaired Axonal Na+ Current by Hindlimb Unloading: Implication for Disuse Neuromuscular Atrophy (2016) (14)
Oromandibular dystonia associated with SCA36 (2013) (14)
HNPP due to a novel missense mutation of the PMP22 gene (2003) (14)
Upregulation of axonal HCN current by methylglyoxal: Potential association with diabetic polyneuropathy (2015) (14)
Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy (2007) (14)
Premovement gating of somatosensory evoked potentials after tibial nerve stimulation (2003) (14)
Compound heterozygote mutations in the SIGMAR1 gene in an oldest‐old patient with amyotrophic lateral sclerosis (2018) (14)
MRI can detect nigral volume loss in patients with Parkinson's disease: evidence from a meta-analysis. (2014) (13)
Choreoathetosis, Dystonia, and Myoclonus in 3 Siblings With Autosomal Recessive Spinocerebellar Ataxia Type 16. (2016) (13)
Late-onset spastic paraplegia type 10 (SPG10) family presenting with bulbar symptoms and fasciculations mimicking amyotrophic lateral sclerosis (2016) (13)
Long-term outcome of severe stroke patients: is the ADL status at discharge from a stroke center indicative of the long-term outcome? (2011) (13)
Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability (2017) (12)
Chapter 37 Abnormal sensorimotor integration in hand dystonia (2006) (12)
Are multifocal motor neuropathy patients underdiagnosed? An epidemiological survey in Japan (2014) (12)
Pathophysiology of weakness in a patient with congenital end‐plate acetylcholinesterase deficiency (2002) (12)
The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis (2016) (12)
Increased variability of axonal excitability in amyotrophic lateral sclerosis (2013) (12)
Val66Met polymorphism of brain-derived neurotrophic factor is associated with idiopathic dystonia (2015) (12)
[A double-blind comparative study to evaluate the efficacy and safety of NerBloc® (rimabotulinumtoxinB) administered in a single dose to patients with cervical dystonia]. (2013) (12)
Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia (2013) (12)
Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan (2002) (12)
Comparison of recording characteristics of monopolar and concentric needle electrodes. (1993) (12)
Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation (2016) (11)
Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia (2014) (11)
Intra-arterial high signals on arterial spin labeling perfusion images predict the occluded internal carotid artery segment (2017) (11)
Effect of photic conditioning on blink reflex recovery function in blepharospasm. (1996) (11)
Ultra-high dose methylcobalamin (E0302) prolongs survival of ALS: Report of 7 years’ randomised double-blind, phase 3 clinical trial (ClinicalTrials.gov NCT00444613) (P7.060) (2015) (10)
Utility of recovery cycle with two conditioning pulses for detection of impaired axonal slow potassium current in ALS (2010) (10)
Threshold-dependent effects on peripheral nerve in vivo excitability properties in the rat (2010) (10)
Botulinum neurotoxin A2 reduces incidence of seizures in mouse models of temporal lobe epilepsy. (2013) (10)
Peripheral Neurology: Case Studies in Electrodiagnosis (1992) (10)
Frequency of emerging positive diffusion-weighted imaging in early repeat examinations at least 24 h after transient ischemic attacks (2013) (10)
[Inter-rater reliability while using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) in patients with cervical dystonia]. (2009) (10)
Spastic paraplegia type 31: A novel REEP1 splice site donor variant and expansion of the phenotype variability. (2018) (10)
Ultrasonographic evaluation of myokymic discharges (2015) (10)
The difference of apparent diffusion coefficient in the middle cerebellar peduncle among parkinsonian syndromes: Evidence from a meta-analysis (2016) (10)
Direct central action of intramuscularly injected botulinum toxin: is it harmful or beneficial? (2013) (9)
Abnormal gating of axonal slow potassium current in cramp-fasciculation syndrome (2015) (9)
[Case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion]. (2014) (9)
Spontaneous brain activity in the sensorimotor cortex in amyotrophic lateral sclerosis can be negatively regulated by corticospinal fiber integrity (2017) (9)
Detection of anti-glutamate receptor ε2 and anti-N-methyl-d-aspartate receptor antibodies in a patient with sporadic Creutzfeldt–Jakob disease (2012) (9)
[Treatment of hemifacial spasm with type A botulinum toxin (AGN 191622): a dose finding study and the evaluation of clinical effect with electromyography]. (1999) (9)
Hereditary neuropathy with liability to pressure palsies: distinguishing clinical and electrophysiological features among patients with multiple entrapment neuropathy (1996) (9)
Enhancement of TNF-α production by ganglioside GM2 in human mononuclear cell culture (1999) (9)
Influence of interleukin-1β gene polymorphism on age-at-onset of spinocerebellar ataxia 6 (SCA6) in Japanese patients (2001) (9)
Diffusion tensor imaging in patients with Creutzfeldt–Jakob disease (2008) (9)
Transverse myelitis and polymyositis associated with antiphospholipid antibody syndrome (2010) (9)
Broad spectrum of dystonia associated with a novel thanatosis‐associated protein domain‐containing apoptosis‐associated protein 1 mutation in a Japanese family with dystonia 6, torsion (2012) (9)
[An adult case of transverse myelitis with erythema infectiosum]. (1992) (9)
Abnormal sensorimotor integration in hand dystonia. (2006) (9)
Longitudinal monitoring with multiple MR techniques in a case of progressive multifocal leukoencephalopathy associated with multiple myeloma. (2014) (9)
Extranodal NK/T‐cell lymphoma, nasal type, manifesting as rapidly progressive dementia without any mass or enhancing brain lesion (2016) (9)
Focal nerve enlargement is not the cause for increased distal motor latency in ALS: Sonographic evaluation (2015) (9)
Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3 (2001) (9)
TAF1 as the Most Plausible Disease Gene for XDP/DYT3 (2007) (9)
The UCHL1 S18Y polymorphism and Parkinson's disease in a Japanese population. (2011) (9)
MR Spectroscopy in Patients with Hereditary Diffuse Leukoencephalopathy with Spheroids and Asymptomatic Carriers of Colony-stimulating Factor 1 Receptor Mutation (2016) (8)
Mutations of optineurin in amyotrophic lateral (2010) (8)
CD16+CD57– Natural Killer Cells in Multifocal Motor Neuropathy (2005) (8)
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. (2022) (8)
Differences in the intra-cerebellar connections and graph theoretical measures between Parkinson's disease and multiple system atrophy (2019) (8)
Autopsy case of severe generalized dystonia and static ataxia with marked cerebellar atrophy (2015) (8)
Successful treatment of stiff person syndrome with sequential use of tacrolimus (2013) (8)
Genetic and functional analysis of KIF5A variants in Japanese patients with sporadic amyotrophic lateral sclerosis (2020) (8)
Vibration-evoked sensory nerve action potentials derived from Pacinian corpuscles. (1993) (8)
SS-1-4 Inter-trial variability of nerve conduction studies: multicenter analysis (1995) (8)
Asymmetric tonic seizures with bilateral parietal lesions resembling frontal lobe epilepsy. (2001) (8)
[Intravenous immunoglobulin therapy in multifocal motor neuropathy]. (1994) (8)
Brain and liver iron accumulation in aceruloplasminemia (2013) (8)
抗利尿ホルモン分泌異常症候群で発症し，橋中心・橋外髄鞘崩壊症を合併した視神経脊髄炎関連疾患の1例 (2014) (7)
Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome (2020) (7)
Puffer fish poisoning, Guillain–Barré syndrome and persistent sodium channels (2005) (7)
Psychiatric Symptoms and Subthalamic Nucleus Stimulation in Parkinson's Disease. A Retrospective Study in Our Japanese Patients (2006) (7)
Asian neurology and stroke (2015) (7)
Effects of anesthetic agents on in vivo axonal HCN current in normal mice (2015) (7)
MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons. (2019) (7)
Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE) (2020) (7)
Diagnosis and treatment of multifocal motor neuropathy (2008) (7)
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report (2019) (7)
[Carpal tunnel syndrome: clinical experience of 61 cases]. (1994) (7)
[Parkin and mitochondria]. (2008) (7)
Increased IP-10 production by blood–nerve barrier in multifocal acquired demyelinating sensory and motor neuropathy and multifocal motor neuropathy (2018) (7)
[Use of botulinum neurotoxin therapy]. (2011) (7)
“One line”: A method for differential diagnosis of parkinsonian syndromes (2019) (7)
Durable effect of very low-frequency repetitive transcranial magnetic stimulation for modulating cortico-spinal neuron excitability (2005) (7)
Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi‐center, open‐label, 52‐week phase 3 trial (2018) (7)
Transmission of survival signals through Delta-like 1 on activated CD4+ T cells (2016) (6)
Mystery Case: Parkinsonism in a diabetic uremic patient (2016) (6)
[Potassium channel dysfunction at the lesion site in multifocal motor neuropathy as revealed by threshold electrotonus]. (1995) (6)
[Pathomechanisms of motor neuron death by mutant TFG]. (2013) (6)
The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan (2019) (6)
Usefulness of the superior cerebellar peduncle for differential diagnosis of progressive supranuclear palsy: A meta-analysis (2017) (6)
Identification and localization of neuron-specific isoform of TAF 1 in rat brain : implications for neuropathology of DYT 3 dystonia (2011) (6)
CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis (2018) (6)
The effect of tremor onset on middle cerebellar peduncle of Parkinson's disease (2015) (6)
[Familial Binswanger-type encephalopathy with Sneddon syndrome]. (1996) (6)
New and emerging indications of botulinum toxin therapy. (2011) (6)
[Neuroradiological study of a possible progressive multifocal leukoencephalopathy using diffusion tensor imaging and proton magnetic resonance spectroscopy]. (2006) (6)
[The clinical usefulness of botulinum toxin type A for spasmodic torticollis and facial spasm]. (1995) (6)
Anti-neuronal antibodies in acute pandysautonomia. (2010) (6)
Long-term suppression of tremor by deep brain stimulation of the ventral intermediate nucleus of the thalamus combined with pallidotomy in hemiparkinsonian patients (2009) (6)
Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP). (2010) (5)
Edrophonium Challenge Test for Blepharospasm (2016) (5)
MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis (2021) (5)
Enhancement of TNF-alpha production by ganglioside GM2 in human mononuclear cell culture. (1999) (5)
[Stiff-Person Syndrome and Related Autoantibodies]. (2013) (5)
シャルコー・マリー・トゥース病に類似した三頭酵素欠損症の成人例 (2017) (5)
FK506 attenuates thymic output in patients with myasthenia gravis (2013) (5)
Differences in cerebellar perfusion between Parkinson's disease and multiple system atrophy (2019) (5)
Texture analysis of sonographic muscle images can distinguish myopathic conditions. (2019) (5)
Selenium deficiency presenting visual disturbance and myelopathy (2014) (5)
Amyotrophic lateral sclerosis: a new diagnostic paradigm (2020) (5)
Generalized dystonia in a patient with a novel mutation in the GLUD1 gene (2012) (5)
Age-dependent texture features in skeletal muscle ultrasonography. (2018) (5)
The susceptibility vessel sign containing two compositions on 3-tesla T2*-weighted image and single corticosubcortical infarct on diffusion-weighted image are associated with cardioembolic stroke (2015) (5)
[Case of methotrexate encephalopathy: findings on diffusion tensor image and correlation with clinical outcome]. (2007) (5)
PS-35-3 Threshold electrotonus in patients with amyotrophic lateral sclerosis: further experience in Japanese subjects (1995) (5)
Long-Term Follow-Up of 12 Patients Treated with Bilateral Pallidal Stimulation for Tardive Dystonia (2021) (5)
A Potential Link between Amyotrophic Lateral Sclerosis and Bullous Pemphigoid: Six New Cases and a Systematic Review of the Literature. (2016) (4)
Age-dependent effects on sensory axonal excitability in normal mice (2016) (4)
Chapter 28 Dystonia (2003) (4)
Classification of needle‐EMG resting potentials by machine learning (2019) (4)
[Diagnosis and treatment of multifocal motor neuropathy (Lewis-Sumner)]. (1999) (4)
Chapter 10 – Transcranial Magnetic Stimulation in Amyotrophic Lateral Sclerosis (2005) (4)
Predictors of neurologic deterioration in patients with small-vessel occlusion and infarcts in the territory of perforating arteries. (2014) (4)
TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2 (2022) (4)
Comparative electrophysiological study of response to botulinum toxin type B in Japanese and Caucasians (2008) (4)
Treatment of Isolated Dystonia with Zolpidem (2016) (4)
[New medications for dystonia]. (2012) (4)
[JETALS: The Japanese Early-stage Trial of high dose methylcobalamin for ALS]. (2019) (4)
Very low-frequency rTMS modulates SEPs over the contralateral hemisphere. (2010) (4)
[Multifocal axonal motor neuropathy associated with anti-ganglioside antibodies]. (1992) (4)
[Dose-response relationship in the treatment of cervical dystonia with botulinum toxin type A (AGN 191622)--a phase II study]. (1995) (4)
Modulation of torsinA expression in the globus pallidus internus is associated with levodopa-induced dyskinesia in hemiparkinsonian rats (2006) (4)
Late-onset spastic paraplegia: Aberrant SPG11 transcripts generated by a novel splice site donor mutation (2015) (4)
MIBG Myocardial Scintigraphy can Predict the Occurrence of Wearing-offPhenomenon in Early-stage ParkinsonÃ¢ÂÂs Disease (2013) (4)
[Electrodiagnosis of neuromuscular diseases--a syndrome of monomelic amyotrophy with spinal hemiatrophy, anti-GM1 antibodies and abnormal F-waves (MASH)]. (1994) (4)
Current Use of Thalamic Vim Stimulation in Treating Parkinson’s Disease (2014) (4)
Velocity of intraneural blood flow is increased in inflammatory neuropathies: sonographic observation (2016) (4)
Fractional anisotropy in the supplementary motor area correlates with disease duration and severity of amyotrophic lateral sclerosis (2016) (4)
Deterministic-tractography-based approach for diagnosis and disease monitoring of amyotrophic lateral sclerosis (2019) (4)
DYT6 in Japan—genetic screening and clinical characteristics of the patients (2014) (4)
Dural Arterivenous Fistula at the Cavernous Sinus Diagnosed by Arterial Spin-labeled Imaging (2017) (4)
Magnetic stimulation in ALS--a single motor unit study. (1996) (4)
Can Pallidal Deep Brain Stimulation Rescue Borderline Dystonia? Possible Coexistence of Functional (Psychogenic) and Organic Components (2020) (4)
Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability (2017) (4)
[Molecular and anatomical bases of dystonia: X-linked recessive dystonia-parkinsonism (DYT3)]. (2005) (4)
F‐wave latency is the most reproducible NCS parameter in repeated studies performed at short intervals (2005) (4)
Randomised double-blind clinical trial of botulinum toxin subtype A2 (A2NTX) in comparison with subtype A1 (onabotulinumtoxinA) (ClinicalTrials.gov NCT01910363) (P4.333) (2015) (4)
Efficacy of Istradefylline for the Treatment of ADCY5‐Related Disease (2020) (4)
A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis. (2017) (3)
Evaluation of the Edrophonium Challenge Test for Cervical Dystonia (2017) (3)
[Sensory-motor disintegration in the basal ganglia disorders]. (2001) (3)
[A case of cerebral air embolism developed during pleural lavage]. (2013) (3)
Who is the primary suspect in acute motor axonal neuropathy? (2003) (3)
Mitochondrial trifunctional protein deficiency: an adult patient with similar progress to Charcot-Marie-Tooth disease. (2017) (3)
[An autopsy case of progressive generalized muscle atrophy over 14 years due to post-polio syndrome]. (2016) (3)
Preferential changes of skeletal muscle echogenicity in myotonic dystrophy type 1 (2017) (3)
Evolution, current status, and way forward for the Asian Oceanian Association of Neurology (2014) (3)
[Treatment of focal dystonia with botulinum toxin]. (1991) (3)
Intrathymic Plasmablasts Are Affected in Patients With Myasthenia Gravis With Active Disease (2021) (3)
Predictors of a Favorable Outcome after Recanalization in Patients with Cerebral Major Vessel Occlusion. (2015) (3)
Nerve conduction study in diabetic polyneuropathy: multicenter analysis on intertrial variability. (1997) (3)
MFN2 transcripts escaping from nonsense-mediated mRNA decay pathway cause Charcot-Marie-Tooth disease type 2A2 (2016) (3)
Usefulness of 3-Tesla magnetic resonance arterial spin-labeled imaging for diagnosis of cranial dural arteriovenous fistula (2017) (3)
[Muscle afferent block for the treatment of writer's cramp]. (1995) (3)
Comparison of efficacy and toxicity between botulinum toxin subtypes A1 and A2 in cynomolgus macaques (2018) (3)
On-period unified Parkinson’s disease rating scale before surgery correlates with differences in outcomes between pallidal and subthalamic stimulation: a meta-analysis (2015) (3)
Exome sequencing identifies a novel intronic mutation in ENG that causes recurrence of pulmonary arteriovenous malformations (2015) (3)
Temporal evolution of sporadic Creutzfeldt–Jakob disease monitored by 3-Tesla MR spectroscopy (2011) (3)
Slow Mandibulo‐Faciolingual Wiggling Tremor Associated with Japanese Encephalitis (2014) (3)
Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: a case-control study of rapidly progressive dementia (2013) (3)
Dural arteriovenous fistula in the superior orbital fissure: A case report (2018) (3)
Thalamic Deep Brain Stimulation for Parkinson’s Disease (2011) (3)
Gait and posture assessments of a patient treated with deep brain stimulation in dystonia using three-dimensional motion analysis systems. (2011) (2)
The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial (2018) (2)
The value of serum uric acid as a prognostic biomarker in amyotrophic lateral sclerosis: Evidence from a meta-analysis (2021) (2)
Short latency vector SEPS: Dual generator of N13 potential (1983) (2)
Amyotrophic lateral sclerosis of long clinical course clinically presenting with progressive muscular atrophy (2018) (2)
Deep learning for identification of fasciculation from muscle ultrasound images (2019) (2)
Ocular myasthenia gravis with anti‐muscle‐specific tyrosine kinase antibodies: Two new cases and a systematic literature review (2016) (2)
Simultaneous Approach to Tandem Occlusion in Acute Ischemic Stroke Patients: Percutaneous Transluminal Angioplasty (PTA) Using Push Wire of Stent Retriever (2019) (2)
PS-52-10 Histopathological and electrophysiological findings in experimental allergic neuritis induced by a synthetic peptide of human myelin P2 protein (1995) (2)
[Treatment of spasticity with botulinum toxin and muscle afferent block]. (1996) (2)
[Inflammatory mechanisms in amyotrophic lateral sclerosis]. (2012) (2)
Guillain-Barré syndrome in a local area in Japan, 2006-2015: An epidemiological and clinical study of 108 patients (2017) (2)
[The value of F-waves in an early electrodiagnosis of the lower cervical cord infarction]. (1996) (2)
PMP22-related disease: A novel splice site acceptor variant and intrafamilial phenotype variability (2019) (2)
IncobotulinumtoxinA for upper- and lower-limb spasticity in Japanese patients (2020) (2)
Lesser motor disability in adulthood: A ten-year follow-up of a dyskinetic patient with ADCY5 mutation (2019) (2)
Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosis (2021) (2)
Monozygotic twins with DYT-TOR1A showing jerking movements and levodopa responsiveness (2021) (2)
[Multifocal demyelinating polyneuropathy with persistent conduction block (Lewis-Sumner syndrome)]. (1990) (2)
Crossed cerebellar hyperperfusion without restricted diffusion in status epilepticus (2013) (2)
PS-56-13 Muscle afferent block by intramuscular injection of lidocaine and ethanol for the treatment of spasmodic torticollis (1995) (2)
Hyperexcitability as a potential cause for diffuse lower motor neuron loss in Isaacs’ syndrome (2013) (2)
[Oculomotor nerve nucleus syndrome; crossed innervation of the superior rectus muscle]. (1983) (2)
Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins (2021) (2)
Electrophysiological studies of adult-type Krabbe's disease (1995) (2)
[Gene mutations in familial amyotrophic lateral sclerosis]. (2011) (2)
Creutzfeldt-Jakob disease manifesting as posterior cortical dementia (2005) (2)
Distinct Incidence of Takotsubo Syndrome Between Amyotrophic Lateral Sclerosis and Synucleinopathies: A Cohort Study (2018) (2)
PS-35-2 Threshold electrotonus in monomelic amyotrophy with spinal hemiatrophy (1995) (2)
Dysphagia in Parkinson's disease. (2016) (2)
Turning on the Left Side Electrode Changed Depressive State to Manic State in a Parkinson’s Disease Patient Who Received Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report (2018) (2)
Chapter 5 Principles of stimulation and recording (2006) (2)
Heterogeneous Muscular Involvement in Inclusion Body Myositis (2010) (2)
[Dystonia genes and elucidation of their roles in dystonia pathogenesis]. (2013) (2)
Rapid-Onset Dystonia-Parkinsonism Phenotype Consistency for a Novel Variant of ATP1A3 in Patients Across 3 Global Populations (2021) (2)
A novel compound heterozygous TH mutation in a Japanese case of dopa-responsive dystonia with mild clinical course. (2018) (1)
Lack of C9orf72 expansion in 406 sporadic and familial cases of idiopathic dystonia in Japan (2015) (1)
[New concept of multifocal motor neuropathy and conduction block]. (2003) (1)
Clinical Uses of a Robot (Hybrid-Assisted Limb or HAL™) in Patients with Post-stroke Spasticity after Botulinum Toxin Injections. (2021) (1)
Movement Disorders in Neurologic and Systemic Disease: The borderland between epilepsy and movement disorders (2014) (1)
[Use of botulinum neurotoxin for spasticity]. (2008) (1)
[Update of multifocal motor neuropathy]. (2013) (1)
[On the mechanisms and diagnosis of conduction disturbances due to demyelination with special reference to multifocal demyelinating neuropathy (Lewis-Sumner)]. (1991) (1)
OnabotulinumtoxinA efficacy in lower limb spasticity: Results of three studies (2013) (1)
Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation. (2017) (1)
Validation of a PCR-based test for the genetic diagnosis of Filipino patients with x-linked dystonia parkinsonism (Xdp) (2015) (1)
Reduced Serum Ceruloplasmin Levels in Cervical Dystonia (2012) (1)
Chapter 38 – Dystonia (2013) (1)
[Migrant sensory neuritis--electrophysiological and pathological study]. (1992) (1)
Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects (2020) (1)
Asian and Oceanian Congress of Neurology 2014: Intraregional and interregional synergy (2015) (1)
Responses of single spinal motoneurons to transcranial magnetic stimulation in patients with ALS (1993) (1)
Frequent hepatic steatosis in ALS: implication for systemic involvement (P6.098) (2015) (1)
Muscle afferent block therapy for oromandibular dystonia (2000) (1)
Pathophysiology of multifocal motor neuropathy (2007) (1)
[Increased variability of membrane potentials in amyotrophic lateral sclerosis]. (2011) (1)
Autopsy-proven coexistence of amyotrophic lateral sclerosis with parkinson’s disease (2015) (1)
Distinguishing features of amyloid polyneuropathy on nerve ultrasound (2017) (1)
Abnormal threshold electrotonus in monomelic amyotrophy with spinal hemiatrophy (1996) (1)
Acute Effect of Subthreshold Low-frequency Repetitive Transcranial Magnetic Stimulation over the Premotor Cortex in Writer's Cramp (2007) (1)
Asymmetry of contingent negative variation in focal dystonia (1993) (1)
Deep Brain Stimulation for Camptocormia Associated with Parkinson’s Disease (2014) (1)
Diagnostic spectrum of multifocal motor neuropathy (2013) (1)
A dual dopaminergic therapy with L-3,4-dihydroxyphenylalanine and chlorpromazine for the treatment of blepharospasm, a focal dystonia: Possible implications for striosomal D1 signaling (2022) (1)
[Threshold tracking for beginners]. (2011) (1)
[A case of hyperglycemic neuropathy with possible dysfunction of axonal excitability]. (2006) (1)
Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease (2019) (1)
Is Nerbloc, the botulinum toxin type b formulation, an effective therapy for cervical dystonia?: In our cases (2017) (1)
[Treatment of chronic inflammatory demyelinating polyradiculoneuropathy(CIDP)--a review]. (2000) (1)
Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan (2021) (1)
[Age-related changes in nervous system]. (1984) (1)
Safety and tolerability of incobotulinumtoxinA for the treatment of upper and lower limb spasticity in Japanese subjects (2018) (1)
[Hopkins syndrome (acute postasthmatic amyotrophy]. (1999) (1)
Multifocal motor neuropathy (2004) (0)
P853: Nerve excitability change by chronic administration of methylglyoxal: implication for diabetic neuropathy (2014) (0)
Statin therapy in myopathic patients with hyperlipidemia (2010) (0)
Pathophysiology of Involuntary Movements (2005) (0)
Investigation of the new prediction method for Ht values during the plasma exchange (2007) (0)
[Ictal electroencephalographic findings and clinical seizure types in postencephalitic epilepsy]. (1994) (0)
[Treatment of Guillain-Barré syndrome with "axonal" involvement by plasma exchange]. (1992) (0)
Haploinsufficiency of KMT2B causes myoclonus-dystonia with impaired psychomotor ability (2017) (0)
92. The differences between 0.2 and 0.8Hz monophasic rTMS effect on SEP in writer’s cramp (2009) (0)
Evolution, current status and way forward for AOAN (2015) (0)
Increased Interleukin-17 In The Cerebrospinal Fluid In Sporadic Creutzfeldt-Jakob Disease (P5.234) (2014) (0)
Usefulness of a novel higher brain dysfunction screening test for evaluating higher brain function in healthy persons. (2017) (0)
Crab claw sign predicts successful recanalization in acute mechanical thrombectomy (2017) (0)
Autopsy-Proven Amyotrophic Lateral Sclerosis Coexisted With Parkinson Disease: A Novel Association Of TDP-43 Proteinopathy And α-Synucleinopathy (P1.056) (2014) (0)
Polymerase Chain Reaction ( PCR ) as alternative method to mouse bioassay for typing of botulinum neurotoxin-producing clostridia (2011) (0)
Clinicopathological co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis (2019) (0)
Schedule of meetings (1995) (0)
PS-39-12 Abnormal median somatosensory evoked potentials in writer's Cramp (1995) (0)
Posterior variant alien hand sign with prominent focal dystonia: A case report (2017) (0)
W24 Threshold electrotonus in experimental models of neuropathies and neuronopathies (1996) (0)
Anticipatory postural adjustments are attenuated in spinocerebellar degeneration (2004) (0)
Oromandibular dystonia: Pathophysiology and clinical features (2016) (0)
Preparation containing botulinum toxin type A highly purified pathogen-derived infant botulism (2007) (0)
Approach for analysis of human thymic epithelial cells (2017) (0)
Abstract T P174: Intra-Arterial Signal on Arterial Spin Labeling Perfusion MRI Can Identify Stagnant Flow in Patients with Acute Middle Cerebral Artery Occlusion (2015) (0)
[Treatment of neurological disorders with botulinum toxin]. (1994) (0)
Botulinum toxins subtypes A1 and A2 were transported via different pathways to the contralateral side (2013) (0)
The possibility of the classification about Ht values using the AR model (2009) (0)
[Recent progress in electrodiagnostic tests in clinical neurology]. (2000) (0)
Peripheral nerve dysfunction in a patient with thyrotoxic periodic paralysis: Evidence from an axonal prolonged exercise test (2021) (0)
PS-25-11 Central motor processing deficit in Parkinson's disease (1995) (0)
1. Pre-movement gating of the somatosensory-evoked potentials recorded from the human thalamus (2008) (0)
Current and emerging therapies for ALS - Pharmacology, nutrition and ventilation (2017) (0)
P14-16 High-frequency SEP components (HFOs) generated in the primary motor cortex of the primates (2010) (0)
Diagnostic criteria and disease biomarkers for ALS (2019) (0)
Response to “Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome” (2016) (0)
SS-11-3 Clinical trial of aldose reductase inhibitor (Epalrestat) in diabetic polyneuropathy: electrophysiological evaluation (1995) (0)
Behavioral and electrophysiological studies of A2NTX and A1LL (2013) (0)
Hereditary spastic paraplegia type 31: A novel splice site donor mutation and intra-familial phenotypic variability (2017) (0)
The effect of istradefylline for Parkinson’s disease: A meta-analysis (2017) (0)
Age-dependent texture characteristics of muscular ultrasound (2017) (0)
P920: Sonographic assessment of nerve and root atrophy in ALS (2014) (0)
Contents lists available at SciVerse ScienceDirect (2013) (0)
IN55-TH-01 Molecular dissection of dystonia (2009) (0)
HOW3-2 NCS-1 (2010) (0)
PS-56-6 Clinical trial of blepharospasm with mixture of types F and A botulinum toxins (1995) (0)
[Dystonia and botulinum toxin therapy]. (1994) (0)
P843: Influence of anesthetic agents on sensory nerve excitability testing in mice (2014) (0)
SS-1 Introduction to conduction block and related physiological backgrounds (2010) (0)
Rapidly progressive dementia and brain atrophy caused by primary central nervous system extranodal NK/T-cell lymphoma, nasal type (P4.096) (2015) (0)
[Effects of Vitamin B12 in Patients with Amyotrophic Lateral Sclerosis and Peripheral Neuropathy]. (2015) (0)
Use of Posterior Tibial Nerve Somatosensory Evoked Potential Mapping in the Differential Diagnosis of Multiple Sclerosis (1988) (0)
FC22.3 Mechanism of therapeutic effects of low-frequency monophasic rTMS over premotor cortex in writer’s cramp (2006) (0)
PS-63-9 Usefulness of non-invasive valsalva test for the diagnosis of autonomic dysfunction in diabetic neuropathy (1995) (0)
Angle-dependent alteration of muscle echo-densities to effectively diagnose myopathic conditions (2017) (0)
Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia–parkinsonism (2013) (0)
[Overview of new research findings]. (2008) (0)
[Oculomotor nucleus syndrome: crossed innervation of the superior rectus muscle]. (1991) (0)
Anti-Glutamate Receptor Epsilon 2 Autoantibodies in Patients with Creutzfeldt-Jakob Disease (S57.002) (2012) (0)
Erratum to: Strategies for treatment of dystonia (2016) (0)
Efficacy and safety of incobotulinumtoxinA in the treatment of lower-limb spasticity in Japanese patients (2021) (0)
A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA (2022) (0)
Contents Vol. 29, 2010 (2010) (0)
Ischemic vessel signs on 3 tesla T2∗-weighted MRI in patients with large vessel disease (2010) (0)
Parkin Gene analysis in Tokushima National Hospital (2013) (0)
PS-6-8 Changes of median somatosensory evoked potentials in preparation for movement (1995) (0)
Clinical features of anti-mitochondrial antibody positive myositis (2017) (0)
The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial (Preprint) (2018) (0)
3-2-11. Peripheral nerve excitability changing in spinocerebellar ataxia type 6 (SCA6) (2017) (0)
Early ultra-high-dose methylcobalamin treatment prolongs survival in amyotrophic lateral sclerosis patients (2015) (0)
Ulnar nerve demyelination within the forearm segment in diabetic patients (2017) (0)
Cohort profile of the Japan Dystonia Consortium: Genetic diagnosis and characteristics of movement disorders in Japan (2018) (0)
Phase 3 trial of ultra-high dose methylcobalamin in early-stage amyotrophic lateral sclerosis (2021) (0)
PS-42-4 Slow corticospinal pathway is activated in patients with upper motor neuron disorders (1995) (0)
SS-8-7 Afferent mechanisms in dystonia (1995) (0)
P545: Selective membrane potential abnormality as a potentialy useful early biomarker in ALS (2014) (0)
Generation of induced pluripotent stem cells from a familial Alzheimer's disease patient (2011) (0)
Brachial plexus injury with Cough attack : case report. Comments (1994) (0)
IncobotulinumtoxinA for Post-stroke Upper Limb Spasticity in Neutralizing Antibody-positive Patients after Botulinum Toxin Therapy: A Report of Two Cases (2022) (0)
Possibility of predicting Ht values during a plasma exchange therapy using back propagation neural network (2007) (0)
Establishing a nationwide disaster management system for neurologically ill patients (2015) (0)
PS-20-4 Hereditary neuropathy with liability to pressure palsies: incidence in patients with multiple entrapment neuropathy (1995) (0)
Proteasome impairment in neural cells derived from HMSN-P patient iPSCs (2017) (0)
P08.10 Motor unit number estimate detects motor axon loss much earlier than clinical onset in SOD1 mutation ALS model rats (2006) (0)
Impaired neural coding of information in CNS demyel ination: activity-dependent conduction block mediated by Na+_K+ pump (2000) (0)
[Treatment of facial spasm using botulinum toxin]. (2003) (0)
Basal ganglia hyperintensity on T1-weighted imaging of a patient with central nervous system metastasis producing carcinoembryonic antigens. (2013) (0)
PO5.5 Excitability Properties Suggest Slow K+ Channel Dysfunction in a Patient with Cramp and Myokymia (2009) (0)
‘Gating’ phenomenon in patients with focal arm dystonia (1995) (0)
[Hopkins syndrome (acute postasthmatic amyotrophy)]. (2000) (0)
A case of enlargement of the right atrium associated with myositis detectedby muscle ultrasonography (2011) (0)
PS-5-8 Effects of electric and photic conditioning on blink reflex recovery function in blepharospasm (1995) (0)
Subject Index Vol. 29, 2010 (2010) (0)
SY4.3 Therapeutic Approaches to Spasticity (2009) (0)
Brainstem and Spinal Motor Neuron Involvement with Optineurin Inclusions in a New Type of Familial Amyotrophic Lateral Sclerosis (P01.108) (2012) (0)
[A sporadic case of startle disease]. (1984) (0)
A2NTX an Effective Substitute for OnabotulinumtoxinA in Poststroke Spasticity (2015) (0)
FC37.2 Movement-related field potentials of dystonia recorded in the human pallidum (2006) (0)
52. Excitability properties suggests slow K+ channel dysfunction in a patient with myokymia (2009) (0)
[Ultrasonography of muscle disease]. (2013) (0)
Molecular epidemiology of dystonia in Japan (2018) (0)
[Pathophysiology in dystonia: functional anatomy of basal ganglia]. (2013) (0)
[Management of carpal tunnel syndrome--"bread and butter" in the United States]. (2007) (0)
S-7-2 Abnormal motor subroutines in dystonia (1995) (0)
Mutations of KMT2B cause involuntary movements with intellectual disability (2017) (0)
Brain And Liver Iron Accumulation Demonstrated By 1.5-tesla and 3-tesla MRI in Aceruloplasminemia (P4.032) (2014) (0)
Evoked fasciculations in patients with amyotrophic lateral sclerosis (1993) (0)
Genetics of dystonia (2014) (0)
Characteristic involvement of muscle ultrasound in myotonic dystrophy type 1 (2017) (0)
ALS-Causing Protein TDP-43 Impairs SREBP2 Cholesterol Regulation (2021) (0)
[Treatment of spasticity with botulinum toxin: implications for molecular targeting therapy for CNS diseases]. (2007) (0)
Far-field potential of the compound muscle action potential as a reliable marker in amyotrophic lateral sclerosis. (2023) (0)
Brachial plexus injury with cough attack: case report. (1994) (0)
A Case of Small Cell Lung Cancer with Diverse Neurological Symptoms due to Paraneoplastic Neurological Syndrome (2016) (0)
Contingent negative variation in patients with writer's camp (1996) (0)
Practical management of botulinum toxin therapy. Introduction. (2011) (0)
S37-7 Long-term effect of repetitive transcranial magnetic stimulation over the premotor cortex for upper limb dystonia (2010) (0)
A potassium channel opener for neuropathy, motor neuron disease and beyond (2011) (0)
Corticospinal/Corticobulbar Tracts (2003) (0)
Muscle afferent block for dystonia and spasticity (1997) (0)
Chapter 8 Current Use of Thalamic Vim Stimulation in Treating Parkinson ’ s Disease (2018) (0)
Differential diagnosis and medical treatment of cervical dystonia (1998) (0)
Additional deep brain stimulation of subthalamic fiber tracts is effective for mobile segmental dystonia (2009) (0)
Investigation of a Classification about Time Series Signal Using SOM (2009) (0)
Is NerBloc, the botulinum toxin type B formulation, an effective therapy for cervical dystonia? (2016) (0)
Anticonvulsants and brain-stem auditory evoked potentials (1985) (0)
Botulinum toxin type A in post-stroke spasticity: Clinical trials with functional measures (2013) (0)
Effect of oxidative stress on splicing of parkin gene (2010) (0)
Effect on mitochondrial gene of Parkin (2011) (0)
[Role of the liaison officer in disaster countermeasures implemented by the Japanese Society of Neurology: Hope for the best and prepare for the worst]. (2020) (0)
Preferential involvement of the fast conducting corticospinal tracts in patients with ALS. (2000) (0)
Difference in glutamate concentration in the thalamus between Parkinson’s disease and multiple system atrophy (2017) (0)
Ulnar neuropathy at the elbow: not simply a compressive neuropathy? (2011) (0)
WE-147. Clinical utility of far-field potential of CMAP (FFP-CMAP) as a neurophysiological marker in ALS (2022) (0)
Utility of emergent examination using MRI for diagnosis of acute cerebral stroke (2006) (0)
7. Short term effect of ultra-high-dose methylcobalamin in ALS: Evaluation with neurophysiological index (2011) (0)
VWA3B mutated in a family with cerebellar ataxia with psychomotor retardation (2014) (0)
Reversibility of ischemic findings on 3-tesla magnetic resonance T2(*)-weighted image after recanalization. (2000) (0)
[IT network establishment for neuropatients]. (2013) (0)
S25-4 Spasticity (2010) (0)
Treatment with Ultra-High Dose of Methylcobalamin Attenuates Motor Dysfunction and Neuropathological Changes in Wobbler Mouse Motor Neuron Disease (P6.004) (2015) (0)
[Lower motor neuron disease (syndrome) associated with anti GM1 antibodies]. (1999) (0)
The effect of noninvasive positive pressure ventilation in amyotrophic lateral sclerosis patients from a Japanese multicenter prospective cohort (2017) (0)
Title : iPSC-based drug repositioning identifies the Src / c-Abl pathway as a therapeutic target for ALS motor neurons (2017) (0)
[Practice guideline for CIDP and MMN 2013]. (2015) (0)
New quantitative method of determining botulinum toxin activity using compound muscle action potential (CMAP) in rats (2016) (0)
Proprioception-related SEPs to passive finger movement in cortical myoclonus (1996) (0)
Title Proteasome impairment in neural cells derived from HMSN-Ppatient iPSCs (2018) (0)
8. Ultrasonographic findings of muscular sarcoidosis—A case report (2011) (0)
136. Long-term effect of repetitive transcranial magnetic stimulation (rTMS) over the premotor cortex for upper limb dystonia (2009) (0)
DS6.3 Pathophysiology of multifocal motor neuropathy (2006) (0)
Erratum to: Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial (2010) (0)
[A Case of Anti-SRP Positive Immune-mediated Necrotizing Myopathy Treated Effectively with Combined Immunotherapy]. (2016) (0)
Pathologic Bases of Abnormal Somatosensory Evoked Potentials in Spinocerebellar Degeneration (1987) (0)
Entrapment neuropathy and beyond (2010) (0)
[Future prospects for botulinum toxin therapy]. (2006) (0)
[Clinical application of threshold tracking: (2) Hereditary demyelinating neuropathy]. (2005) (0)
Direct cerebello-striatal loop in dystonia as a possible new target for deep brain stimulation: A revised view of subcortical pathways involved (2022) (0)
Multimodal analysis based on high‐field magnetic resonance and motor evoked potentials: A case report of multiple sclerosis (2017) (0)
TU-227. Temporal change of giant somatosensory evoked potentials in brainstem infarction (2022) (0)
Neck pain and calcium deposition (2007) (0)
Long-term effect of repetitive transcranial magnetic stimulation over the premotor cortex for writer's cramp (2009) (0)
Basal ganglia abnormalities in diabetic uremic syndrome (P1.178) (2015) (0)
Efficacy and safety of ultra-high dose methylcobalamin in early stage amyotrophic lateral sclerosis: Results of a randomized, double-blind, phase 3 trial (JETALS) (2021) (0)
Gene analysis of familial Parkinson's disease in Tokushima National Hospital of 2016-2017 (2018) (0)
[Recent advances in evoked potentials: physiological bases for understanding somatosensory evoked potentials]. (1990) (0)
Establishment of an alternative potency test for botulinum neurotoxin type A using muscle action potential change in rats (2013) (0)
PS-25-8 Dissociation of midline component of contingent negative variation (CNV) and bereitschaftspotential (BP) in Parkinson's disease (1995) (0)
Influence for functional outcome by different antiplatelet drugs; acetylsalicylic acid and cilostazol (2014) (0)
Protocol The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis ( JETALS ) : Protocol for a Randomized Controlled Trial (2018) (0)
[Torsion dystonia]. (1999) (0)
Remede contre l'hypermyotonie (2003) (0)
Electrophysiological study for assessment of botulinum toxin type A2 compared with type A1 in healthy volunteers (2013) (0)
Examination of Cell Viability using the primary culture system of skin fibroblasts (2011) (0)
Sensory-motor link in focal dystonias (1997) (0)
[Botulinum toxin trial for spasticity]. (1992) (0)
Induction of astrocyte differentiation from human induced pluripotent stem cells carrying mutant SOD1 (2011) (0)
Clinical Diagnosis of Involuntary Movements (2003) (0)
Screening of the SOD1, TARDBP and FUS mutations and the pathological studies in Japanese cases with familial and sporadic amyotrophic lateral sclerosis (2012) (0)
[A new rehabilitation strategy for patients with Parkinson disease: a proposal of mentality-orientated rehabilitation]. (2011) (0)
Title iPSC-Based Compound Screening and In�Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer ’ s Disease (2018) (0)
Acute exacerbation of type II alexander disease after traumatic brain injury (2017) (0)
An autopsied case with novel mutated hereditary diffuse leukoencephalopathy with spheroid (HDLS) (2017) (0)
P3-25 Threshold-dependent effects on peripheral nerve in vivo excitability properties in the rat (2010) (0)
A case of sarcoidosis detected by muscle ultrasonography (2012) (0)
3-2-02. Texture Analysis of Muscle Ultrasound can differentiate myopathic conditions (2017) (0)
Muscle afferent block by intramuscular injection of lidocaine for the treatment of oromandibular dystonia (1997) (0)
Inversed champagne bottle type muscle atrophy observed in acromegaly (2009) (0)
Late-Onset Spastic Paraplegia Type 10 (SPG10) Family Presenting with Bulbar Symptoms - Primary Lateral Sclerosis (PLS) Mimic (P2.102) (2015) (0)
Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients (2023) (0)
Neuropathological investigation of transgenic mice overexpressing hTFG harboring HMSN-P mutation (2017) (0)
Acute Effect ofSubthreshold Low-frequency RepetitiveTranscranialMagnetic Stimulation overthe Premotor Cortex inWriter's Cramp (2015) (0)
Do stroke patients get to hospital in time for treatment? Results from national neurology registry (2017) (0)
[Pathophysiology and new treatment for hereditary neuropathy]. (2004) (0)
Improved Outcome after Repeated Injections of Botulinum Toxin for Treatment of Spasmodic Torticollis and Axial Dystonia: Experience with Japanese Botulinum Toxin A (1993) (0)
Modification of multiple ion channel functions in vivo by pharmacological inhibition: observation by threshold tracking and modeling. (2017) (0)
[Diagnostic criteria, disease stage, and severity in diabetic neuropathy]. (2005) (0)
[Anti-ganglioside antibodies and motor neuropathy in relation to nerve conduction block]. (1992) (0)
[Treatment of neurological disorders with botulinum toxin: recent progress]. (1997) (0)
Muscle ultrasound to differentiate myopathic conditions: Utililty of texture analysis (2017) (0)
15. Does the selective membrane potential abnormality precede the onset of the ALS? (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ryuji Kaji?

Ryuji Kaji is affiliated with the following schools:

Ryuji Kaji's Academic­Influence.com Rankings